[PDF] Evidence to support the interchangeability of generic glatiramer (Brabio®) with the branded version (Copaxone®)

Source:
Specialist Pharmacy Service
Publisher:
Specialist Pharmacy Service
Publication date:
10 May 2018

Abstract

This evidence review concludes that there is robust evidence to support the case for switching patients from branded to generic glatiramer as a means of reducing treatment costs without compromising safety or effectiveness.